CLPT Stock Price, Chart, Stats & News

ClearPoint Neuro, Inc.
Save
539.27M
Market cap
–
Current P/E
12.11x
Forward P/E
CLPT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 61.38% |
Operating margin | -65.36% |
Pretax margin | -68.93% |
Net margin | -69.08% |
Effective tax rate | -0.22% |
ROA | -26.13% |
ROE | -122.17% |
D/E | 2.08x |
Interest coverage ratio | -18.22x |
CLPT valuation
P/E | – |
P/S | 7.30x |
P/B | 9.17x |
P/CF | -10.73x |
P/FCF | -11.04x |
P/OCF | -10.73x |
PEG | 1.21x |
EV multiple | -11.49x |
About
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain.
Similar securities
Based on sector and market capitalization
Report issue











